• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同人群肝细胞癌的风险预测模型。

Risk prediction models for hepatocellular carcinoma in different populations.

作者信息

Ma Xiao, Yang Yang, Tu Hong, Gao Jing, Tan Yu-Ting, Zheng Jia-Li, Bray Freddie, Xiang Yong-Bing

机构信息

1State Key Laboratory of Oncogene and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200032, China;; 2Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200032, China;

1State Key Laboratory of Oncogene and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200032, China;

出版信息

Chin J Cancer Res. 2016 Apr;28(2):150-60. doi: 10.21147/j.issn.1000-9604.2016.02.02.

DOI:10.21147/j.issn.1000-9604.2016.02.02
PMID:27199512
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4865607/
Abstract

Hepatocellular carcinoma (HCC) is a malignant disease with limited therapeutic options due to its aggressive progression. It places heavy burden on most low and middle income countries to treat HCC patients. Nowadays accurate HCC risk predictions can help making decisions on the need for HCC surveillance and antiviral therapy. HCC risk prediction models based on major risk factors of HCC are useful and helpful in providing adequate surveillance strategies to individuals who have different risk levels. Several risk prediction models among cohorts of different populations for estimating HCC incidence have been presented recently by using simple, efficient, and ready-to-use parameters. Moreover, using predictive scoring systems to assess HCC development can provide suggestions to improve clinical and public health approaches, making them more cost-effective and effort-effective, for inducing personalized surveillance programs according to risk stratification. In this review, the features of risk prediction models of HCC across different populations were summarized, and the perspectives of HCC risk prediction models were discussed as well.

摘要

肝细胞癌(HCC)是一种恶性疾病,因其进展迅速,治疗选择有限。治疗HCC患者给大多数低收入和中等收入国家带来了沉重负担。如今,准确的HCC风险预测有助于就HCC监测和抗病毒治疗的必要性做出决策。基于HCC主要危险因素的HCC风险预测模型对于为具有不同风险水平的个体提供适当的监测策略是有用且有帮助的。最近,通过使用简单、有效且易于使用的参数,提出了几种针对不同人群队列估计HCC发病率的风险预测模型。此外,使用预测评分系统评估HCC发展可为改善临床和公共卫生方法提供建议,使其更具成本效益和效率效益,以便根据风险分层制定个性化监测计划。在本综述中,总结了不同人群中HCC风险预测模型的特点,并讨论了HCC风险预测模型的前景。

相似文献

1
Risk prediction models for hepatocellular carcinoma in different populations.不同人群肝细胞癌的风险预测模型。
Chin J Cancer Res. 2016 Apr;28(2):150-60. doi: 10.21147/j.issn.1000-9604.2016.02.02.
2
Risk prediction of hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy.抗病毒治疗时代乙型肝炎病毒相关肝细胞癌的风险预测。
World J Gastroenterol. 2013 Dec 21;19(47):8867-72. doi: 10.3748/wjg.v19.i47.8867.
3
Surveillance for hepatocellular carcinoma in chronic viral hepatitis: Is it time to personalize it?慢性病毒性肝炎肝细胞癌的监测:是否到了个体化的时代?
World J Gastroenterol. 2021 Sep 7;27(33):5536-5554. doi: 10.3748/wjg.v27.i33.5536.
4
Risk prediction of hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy.抗病毒治疗时代乙型肝炎病毒相关肝细胞癌的风险预测。
World J Gastroenterol. 2013 Oct 21;19(39):6515-22. doi: 10.3748/wjg.v19.i39.6515.
5
Prediction models of hepatocellular carcinoma development in chronic hepatitis B patients.慢性乙型肝炎患者肝细胞癌发生的预测模型
World J Gastroenterol. 2016 Oct 7;22(37):8314-8321. doi: 10.3748/wjg.v22.i37.8314.
6
Prediction model of hepatitis B virus-related hepatocellular carcinoma in patients receiving antiviral therapy.接受抗病毒治疗的乙型肝炎病毒相关肝细胞癌患者的预测模型
J Formos Med Assoc. 2023 Dec;122(12):1238-1246. doi: 10.1016/j.jfma.2023.05.029. Epub 2023 Jun 15.
7
Hepatocellular carcinoma prediction beyond year 5 of oral therapy in a large cohort of Caucasian patients with chronic hepatitis B.一大群慢性乙型肝炎白种患者接受口服治疗5年后的肝细胞癌预测
J Hepatol. 2020 Jun;72(6):1088-1096. doi: 10.1016/j.jhep.2020.01.007. Epub 2020 Jan 22.
8
Personalized surveillance for hepatocellular carcinoma in cirrhosis - using machine learning adapted to HCV status.基于机器学习和 HCV 状态调整的肝硬化肝细胞癌个体化监测
J Hepatol. 2020 Dec;73(6):1434-1445. doi: 10.1016/j.jhep.2020.05.052. Epub 2020 Jun 29.
9
Deep learning model for prediction of hepatocellular carcinoma in patients with HBV-related cirrhosis on antiviral therapy.用于预测接受抗病毒治疗的乙肝相关肝硬化患者肝细胞癌的深度学习模型。
JHEP Rep. 2020 Aug 30;2(6):100175. doi: 10.1016/j.jhepr.2020.100175. eCollection 2020 Dec.
10
Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification.用于风险分层的酒精或非酒精性脂肪性肝病相关肝硬化患者肝细胞癌风险的预测模型。
J Hepatol. 2019 Sep;71(3):523-533. doi: 10.1016/j.jhep.2019.05.008. Epub 2019 May 28.

引用本文的文献

1
Development and validation of personalised risk prediction models for early detection and diagnosis of primary liver cancer among the English primary care population using the QResearch® database: research protocol and statistical analysis plan.利用QResearch®数据库开发并验证用于英国初级保健人群原发性肝癌早期检测和诊断的个性化风险预测模型:研究方案与统计分析计划
Diagn Progn Res. 2022 Oct 20;6(1):21. doi: 10.1186/s41512-022-00133-x.
2
Frequency and Outcomes of Abnormal Imaging in Patients With Cirrhosis Enrolled in a Hepatocellular Carcinoma Surveillance Program.肝硬化患者纳入肝细胞癌监测计划后的异常影像学表现的频率和结局。
Liver Transpl. 2019 Mar;25(3):369-379. doi: 10.1002/lt.25398.
3
Clinicopathological features and surgical outcomes of four rare subtypes of primary liver carcinoma.四种罕见原发性肝癌亚型的临床病理特征及手术结果
Chin J Cancer Res. 2018 Jun;30(3):364-372. doi: 10.21147/j.issn.1000-9604.2018.03.08.
4
A national report from China Liver Transplant Registry: steroid avoidance after liver transplantation for hepatocellular carcinoma.中国肝脏移植登记处的一份全国性报告:肝细胞癌肝移植术后避免使用类固醇。
Chin J Cancer Res. 2017 Oct;29(5):426-437. doi: 10.21147/j.issn.1000-9604.2017.05.07.
5
Prediction and prophylaxis of hepatocellular carcinoma occurrence and postoperative recurrence in chronic hepatitis B virus-infected subjects.慢性乙型肝炎病毒感染患者肝细胞癌发生及术后复发的预测与预防
World J Gastroenterol. 2016 Aug 7;22(29):6565-72. doi: 10.3748/wjg.v22.i29.6565.

本文引用的文献

1
Hepatitis B Virus Combo Mutations Improve the Prediction and Active Prophylaxis of Hepatocellular Carcinoma: A Clinic-Based Cohort Study.乙肝病毒组合突变改善肝细胞癌的预测和主动预防:一项基于临床的队列研究
Cancer Prev Res (Phila). 2015 Oct;8(10):978-88. doi: 10.1158/1940-6207.CAPR-15-0160. Epub 2015 Aug 19.
2
Validation of hepatitis B virus-related hepatocellular carcinoma prediction models in the era of antiviral therapy.抗病毒治疗时代乙型肝炎病毒相关肝细胞癌预测模型的验证。
Hepatology. 2015 Dec;62(6):1757-66. doi: 10.1002/hep.28115. Epub 2015 Oct 16.
3
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update.《亚太地区慢性乙型肝炎管理共识声明:2012年更新版》
Hepatol Int. 2012 Jun;6(3):531-61. doi: 10.1007/s12072-012-9365-4. Epub 2012 May 17.
4
Global cancer statistics, 2012.全球癌症统计数据,2012 年。
CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4.
5
Development of risk scoring system for stratifying population for hepatocellular carcinoma screening.开发用于分层人群进行肝细胞癌筛查的风险评分系统。
Hepatology. 2015 Jun;61(6):1934-44. doi: 10.1002/hep.27610. Epub 2015 Apr 13.
6
Comparison of acoustic radiation force impulse imaging and transient elastography for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B.比较声辐射力脉冲成像和瞬时弹性成像在慢性乙型肝炎患者肝纤维化无创评估中的应用
Ultrasound Med Biol. 2015 Jan;41(1):7-14. doi: 10.1016/j.ultrasmedbio.2014.07.018. Epub 2014 Oct 11.
7
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.全球癌症发病与死亡:GLOBOCAN 2012 数据源、方法与主要模式。
Int J Cancer. 2015 Mar 1;136(5):E359-86. doi: 10.1002/ijc.29210. Epub 2014 Oct 9.
8
Risk prediction of hepatocellular carcinoma in patients with cirrhosis: the ADRESS-HCC risk model.肝硬化患者肝细胞癌风险预测:ADRESS-HCC 风险模型。
Cancer. 2014 Nov 15;120(22):3485-93. doi: 10.1002/cncr.28832. Epub 2014 Jul 16.
9
MR elastography for the assessment of hepatic fibrosis in patients with chronic hepatitis B infection: does histologic necroinflammation influence the measurement of hepatic stiffness?磁共振弹性成像评估慢性乙型肝炎感染患者的肝纤维化:组织学坏死性炎症是否会影响肝硬度测量?
Radiology. 2014 Oct;273(1):88-98. doi: 10.1148/radiol.14132592. Epub 2014 Jun 2.
10
Prospective cohort studies of association between family history of liver cancer and risk of liver cancer.前瞻性队列研究家族肝癌史与肝癌风险之间的关系。
Int J Cancer. 2014 Oct 1;135(7):1605-14. doi: 10.1002/ijc.28792. Epub 2014 Mar 7.